Overview
Pancreatic agenesis associated with holoprosencephaly syndrome is a rare genetic disorder characterized by developmental defects in both the pancreas and forebrain, often linked to mutations in genes critical for embryonic development such as CNOT1 1.Diagnosis
Genetic Testing: Identification of CNOT1 mutations, particularly c.1603C>T (p.Arg535Cys), is crucial 1.
Imaging Studies: MRI or CT scans to assess brain anomalies indicative of holoprosencephaly 1.
Pancreatic Function Tests: Evaluation for absence or severe dysfunction of pancreatic tissue 1.
Phenotypic Criteria: Beyond CNOT1 mutations, consider a broader spectrum including craniofacial anomalies, polydactyly, and brain defects like microcephaly and agenesis of the corpus callosum 2.Management
Supportive Care: Focus on managing symptoms and complications such as feeding difficulties and neurological deficits 1.
Nutritional Support: Pancreatic enzyme replacement therapy and specialized nutritional plans for pancreatic insufficiency 1.
Neurological Interventions: Tailored to individual brain anomalies, potentially including surgical interventions for specific defects 1.
Genetic Counseling: Essential for families to understand recurrence risks and implications 1.Special Populations
Pediatrics: Early intervention for developmental delays and feeding issues is critical 1.
Comorbidities: Consider additional skeletal and craniofacial anomalies requiring multidisciplinary care 13.Key Recommendations
Genetic Testing for CNOT1 Mutations: Essential for diagnosis of pancreatic agenesis with holoprosencephaly syndrome (Evidence: Strong 1).
Comprehensive Imaging: Utilize MRI or CT to fully assess brain malformations (Evidence: Moderate 1).
Multidisciplinary Support: Implement care involving pediatricians, neurologists, and geneticists to address varied clinical manifestations (Evidence: Expert opinion 13).References
1 De Franco E, Watson RA, Weninger WJ, Wong CC, Flanagan SE, Caswell R et al.. A Specific CNOT1 Mutation Results in a Novel Syndrome of Pancreatic Agenesis and Holoprosencephaly through Impaired Pancreatic and Neurological Development. American journal of human genetics 2019. link
2 Lurie IW, Wulfsberg EA. "Holoprosencephaly-polydactyly" (pseudotrisomy 13) syndrome: expansion of the phenotypic spectrum. American journal of medical genetics 1993. link
3 Martin AO, Perrin JC, Muir WA, Ruch E, Schafer IA. An autosomal dominant midline cleft syndrome resembling familial holoprosencephaly. Clinical genetics 1977. link